171 related articles for article (PubMed ID: 15685486)
41. Active and intelligent inhaler device development.
Tobyn M; Staniforth JN; Morton D; Harmer Q; Newton ME
Int J Pharm; 2004 Jun; 277(1-2):31-7. PubMed ID: 15158967
[TBL] [Abstract][Full Text] [Related]
42. [Inhalers and inhalation techniques in the treatment of asthma and chronic obstructive pulmonary disease].
Fuglø-Mortensen R; Lange P; Mortensen J
Ugeskr Laeger; 2019 Aug; 181(33):. PubMed ID: 31495355
[TBL] [Abstract][Full Text] [Related]
43. [The importance of selecting the right type of inhaler for patients with asthma and chronic obstructive pulmonary disease (COPD)].
Larsson K; Bjermer L; Svartengren M
Lakartidningen; 2019 Feb; 116():. PubMed ID: 30720857
[TBL] [Abstract][Full Text] [Related]
44. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD.
Schulte M; Osseiran K; Betz R; Wencker M; Brand P; Meyer T; Haidl P
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):321-8. PubMed ID: 18823257
[TBL] [Abstract][Full Text] [Related]
45. Asthma and COPD. Inhalation therapy--clarity or confusion?
Seeto L; Lim S
Aust Fam Physician; 2001 Jun; 30(6):557-61. PubMed ID: 11458583
[TBL] [Abstract][Full Text] [Related]
46. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Laube BL
Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
[TBL] [Abstract][Full Text] [Related]
47. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert MP
Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
[TBL] [Abstract][Full Text] [Related]
48. Could interchangeable use of dry powder inhalers affect patients?
Price D; Summers M; Zanen P
Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
[TBL] [Abstract][Full Text] [Related]
49. Are outcomes the same with all dry powder inhalers?
Thomas M; Williams AE
Int J Clin Pract Suppl; 2005 Dec; (149):33-5. PubMed ID: 16280002
[TBL] [Abstract][Full Text] [Related]
50. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
Dhand R
Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
[TBL] [Abstract][Full Text] [Related]
51. Development of Respimat(®) Soft Mist™ Inhaler and its clinical utility in respiratory disorders.
Dalby RN; Eicher J; Zierenberg B
Med Devices (Auckl); 2011; 4():145-55. PubMed ID: 22915941
[TBL] [Abstract][Full Text] [Related]
52. Use of gamma scintigraphy to evaluate the performance of new inhalers.
Newman SP
J Aerosol Med; 1999; 12 Suppl 1():S25-31. PubMed ID: 10623338
[TBL] [Abstract][Full Text] [Related]
53. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
Munzel U; Marschall K; Fyrnys B; Wedel M
Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
[TBL] [Abstract][Full Text] [Related]
54. [Teaching the inhalation manoeuvre to asthmatic children by means of visual feedback].
Kamin W; Kreplin A
Pneumologie; 2007 Mar; 61(3):150-6. PubMed ID: 17342574
[TBL] [Abstract][Full Text] [Related]
55. Dry powder inhalers for pulmonary drug delivery.
Frijlink HW; De Boer AH
Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
[TBL] [Abstract][Full Text] [Related]
56. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler.
Dhand R; Eicher J; Hänsel M; Jost I; Meisenheimer M; Wachtel H
Int J Chron Obstruct Pulmon Dis; 2019; 14():509-523. PubMed ID: 30880941
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.
Worth Longest P; Hindle M
J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):99-112. PubMed ID: 18956950
[TBL] [Abstract][Full Text] [Related]
58. Do healthcare professionals think that dry powder inhalers can be used interchangeably?
Price D
Int J Clin Pract Suppl; 2005 Dec; (149):26-9. PubMed ID: 16280000
[TBL] [Abstract][Full Text] [Related]
59. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
60. Use of dry powder inhalers in COPD.
Wilson DS; Gillion MS; Rees PJ
Int J Clin Pract; 2007 Dec; 61(12):2005-8. PubMed ID: 17997806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
